Circuit to construct mapping: a mathematical tool for assisting the diagnosis and treatment in major depressive disorder

Frontiers in Psychiatry
Natalia Z BielczykPaul H E Tiesinga

Abstract

Major depressive disorder (MDD) is a serious condition with a lifetime prevalence exceeding 16% worldwide. MDD is a heterogeneous disorder that involves multiple behavioral symptoms on the one hand and multiple neuronal circuits on the other hand. In this review, we integrate the literature on cognitive and physiological biomarkers of MDD with the insights derived from mathematical models of brain networks, especially models that can be used for fMRI datasets. We refer to the recent NIH research domain criteria initiative, in which a concept of "constructs" as functional units of mental disorders is introduced. Constructs are biomarkers present at multiple levels of brain functioning - cognition, genetics, brain anatomy, and neurophysiology. In this review, we propose a new approach which we called circuit to construct mapping (CCM), which aims to characterize causal relations between the underlying network dynamics (as the cause) and the constructs referring to the clinical symptoms of MDD (as the effect). CCM involves extracting diagnostic categories from behavioral data, linking circuits that are causal to these categories with use of clinical neuroimaging data, and modeling the dynamics of the emerging circuits with attract...Continue Reading

References

Jul 1, 1990·Trends in Neurosciences·G E Alexander, M D Crutcher
Jan 1, 1972·Biophysical Journal·H R Wilson, J D Cowan
Nov 1, 1965·The American Journal of Psychiatry·J J Schildkraut
Oct 27, 1997·Annals of Internal Medicine·V Fuster, I S Nash
Jun 12, 1998·Nature·D J Watts, S H Strogatz
Feb 24, 2001·Proceedings of the National Academy of Sciences of the United States of America·M E RaichleG L Shulman
Mar 27, 2001·Nature·M C Anderson, C Green
Apr 5, 2002·Neuron·Eric J NestlerLisa M Monteggia
Apr 16, 2002·Seminars in Clinical Neuropsychiatry·Christine Heim, Charles B Nemeroff
Oct 18, 2002·Neuron·Wolfram Schultz
Dec 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Michael D GreiciusVinod Menon
Feb 25, 2003·Neuroreport·Martina T MitterschiffthalerTonmoy Sharma
Apr 2, 2003·The American Journal of Psychiatry·Irving I Gottesman, Todd D Gould
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Ronald C KesslerUNKNOWN National Comorbidity Survey Replication
Sep 2, 2003·NeuroImage·K J FristonW Penny
Mar 2, 2005·Nature Reviews. Neuroscience·Eero Castrén
Mar 8, 2005·Neuron·Helen S MaybergSidney H Kennedy
Jun 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Michael D FoxMarcus E Raichle
Jul 27, 2005·Biological Psychiatry·Paul A KeedwellMary L Phillips
Jan 13, 2006·Trends in Cognitive Sciences·Russell A Poldrack
Jan 18, 2006·Lancet·Klaus P EbmeierJ Douglas Steele
May 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·M E J Newman
Jul 25, 2006·Nature Neuroscience·Genela MorrisHagai Bergman
Sep 2, 2006·Proceedings of the National Academy of Sciences of the United States of America·J S DamoiseauxC F Beckmann
Feb 7, 2007·Physical Review Letters·Changsong ZhouJürgen Kurths
Mar 3, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·William W SeeleyMichael D Greicius
Jun 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Christopher J HoneyOlaf Sporns
Aug 19, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tom JohnstoneRichard J Davidson
Aug 25, 2007·Annual Review of Clinical Psychology·Andrew Mathews, Colin MacLeod
Sep 14, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Christopher Pittenger, Ronald S Duman
Feb 27, 2008·Brain : a Journal of Neurology·Yong LiuTianzi Jiang
May 14, 2008·Journal of Experimental Psychology. General·Naomi P FriedmanJohn K Hewitt
Aug 2, 2008·The European Journal of Neuroscience·Edmund T RollsGustavo Deco
Aug 5, 2008·Trends in Neurosciences·Carmine M Pariante, Stafford L Lightman
Aug 21, 2008·Nature Reviews. Neuroscience·Edmund T RollsGeorg Winterer
Jan 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yvette I ShelineMarcus E Raichle
Apr 3, 2009·The Journal of Clinical Investigation·Helen S Mayberg

❮ Previous
Next ❯

Methods Mentioned

BETA
MDD
pharmacotherapy

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.